biopharmaceutical company
Issues related to tax reform. General issues related to Medicare and Medicaid. H.R.5122, To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models; issues related to Demonstration Programs. Implementation issues related to the Patient Protection and Affordable Care Act (P.L.111-148) and the Food and Drug Administration Safety and Innovation Act (P.L.112-144). H.R.34, 21st Century Cures Act (P.L.114-255). S.2912, Trickett Wendler Right to Try Act of 2016. Issues related to health care, the Food and Drug Administration (FDA), oncology coverage and the 340B Program. H.R.5054/S.2956, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017; H.R.2028, Further Continuing and Security Assistance Appropriations Act, 2017 (P.L.114-254); FDA related issues.
TAX - Taxation/Internal Revenue Code MMM - Medicare/Medicaid HCR - Health Issues BUD - Budget/Appropriations
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
CROSSROADS STRATEGIES, LLC
800 North Capitol Street, NW, Suite 800, Washington, DC, 20002, US
JOHN GREEN STEWART HALL HUNTER MOORHEAD MATT WISE STEVE TILTON TODD MATTHEW WEISS MATHEW LAPINSKI ANNE BRADY JAKE PERRY ELIZABETH ALYSON HART JOHN GREEN STEWART HALL HUNTER MOORHEAD MATT WISE STEVE TILTON TODD MATTHEW WEISS MATHEW LAPINSKI ANNE BRADY JAKE PERRY ELIZABETH ALYSON HART JOHN GREEN STEWART HALL HUNTER MOORHEAD MATT WISE STEVE TILTON TODD MATTHEW WEISS MATHEW LAPINSKI ANNE BRADY JAKE PERRY ELIZABETH ALYSON HART JOHN GREEN STEWART HALL HUNTER MOORHEAD MATT WISE STEVE TILTON TODD MATTHEW WEISS MATHEW LAPINSKI ANNE BRADY JAKE PERRY ELIZABETH ALYSON HART